Media Center
Press Releases
29 Jan 13

Back to posts

Generic Statins to Slash Global Market Value by 2018

The introduction of generic statins has kick-started a decline that will see the global statins market lose over US$7 billion in revenue by 2018, states the latest report by business intelligence providers GBI Research.

The firm’s new report* forecasts the worldwide statins market to drop from a 2012 valuation of US$19.7 billion to US$12.2 billion just five years later at a negative Compound Annual Growth Rate (CAGR) of 7.7%.

Statins, a category of drugs employed to lower cholesterol levels, are increasingly under threat from non-statins and combination therapies (a mixture of statins and non-statins), but the primary threat to global revenue lies with the rise of generic variants.

The global statins market declined in 2006 and 2007 due to patent expiries for Merck’s Zocor (simvastatin) and Pravachol (pravastatin), but revenue has remained steady until recently. However, the expiry of Pfizer’s blockbuster drug Lipitor (atorvastatin calcium) in 2011, followed by the immediate launch of generics, has intensified the competition in the statins market and will restrain the commercial opportunities for upcoming products.

The US, the largest single contributor to the global statins market, is expected to demonstrate substantial loss of revenue in the near future and is forecast to slip from a valuation of US$10 billion last year to US$5.8 billion in 2018 – a depreciation of 42% in just six years.

GBI Research’s new report predicts that due to the effects of numerous patent expiries, the generic share of the global statins market will reach 34% in 2018 from an 11% share in 2011.



*Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share

This report gives insights into the share of generics in the global statins market for the years 2011 to 2018. The report examines the dyslipidemia treatment usage patterns in the US, the top five countries of Europe (The UK, France, Germany, Spain and Italy), and Japan.This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GBI Research’s team of industry experts.


GBI Research is a market-leading provider of business intelligence reports,offering actionable data and forecasts based on the insights of key industry leaders to ensure you stayup-to-date with the latest emerging trends in your markets.

For further details, please Contact Us.

Latest Press Releases


Send this to a colleague

I have read and accept terms and conditions and privacy policy